Sign In
Buy MGTX
$9.39
+0.150 (+1.62%)
At Close: Jun 03, 2026
MeiraGTx Reports Third Quarter 2020 Financial Results
08:30am, Thursday, 05'th Nov 2020
LONDON and NEW YORK,, Nov. 05, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial results for the
12-Month Dose Escalation Data from Phase 1/2 Clinical Trial to be Presented 12-Month Dose Escalation Data from Phase 1/2 Clinical Trial to be Presented
MeiraGTx Is A Buy With Multiple Near-Term Catalysts As The Stock Is Weighed Down By Negative Sentiment
02:51pm, Monday, 24'th Aug 2020
MGTX share price has failed to recover to pre-COVID-19 levels despite promising developments. MGTX partnership with Janssen on several lead indications.
Did Hedge Funds Make The Right Call On MeiraGTx Holdings plc (MGTX) ?
01:42pm, Wednesday, 12'th Aug 2020
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail invest
MeiraGTx Reports Second Quarter 2020 Financial Results
12:00pm, Thursday, 06'th Aug 2020
\- Positive initial data from Phase 1/2 clinical trial of AAV-RPGR for the treatment of XLRP recently presented \- AAV-RPGR to advance into Phase 3 Lumeos clinical trial \- Expands manufacturing cap
MeiraGTx Expands Leadership Team with Appointment of Robert K. Zeldin, M.D. as Chief Medical Officer
12:30pm, Wednesday, 05'th Aug 2020
LONDON and NEW YORK, Aug. 05, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced the appointment of Robert
MeiraGTx Sees Hammer Chart Pattern: Time to Buy?
12:18pm, Monday, 27'th Jul 2020
MeiraGTx has been struggling lately, but the selling pressure may be coming to an end soon.
MeiraGTx Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
06:38pm, Monday, 20'th Jul 2020
MeiraGTx reports encouraging data for ocular gene therapy. Eli Lilly posts positive update for Mirikizumab.
Do Insiders Own Lots Of Shares In MeiraGTx Holdings plc (NASDAQ:MGTX)?
12:45pm, Friday, 17'th Jul 2020
Every investor in MeiraGTx Holdings plc (NASDAQ:MGTX) should be aware of the most powerful shareholder groups...
• Data being presented at the American Society of Retina Specialists (ASRS) 2020 Virtual Annual Meeting • Significant improvements demonstrated after treatment in Phase 1/2.
MeiraGTx Holdings PLC (MGTX) Moves to Strong Buy: Rationale Behind the Upgrade
04:00pm, Friday, 26'th Jun 2020
MeiraGTx Holdings PLC (MGTX) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Hedge Funds Aren’t Crazy About MeiraGTx Holdings plc (MGTX) Anymore
03:07am, Wednesday, 24'th Jun 2020
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Ev
MeiraGTx Announces Move to Virtual-Only Format for 2020 Annual General Meeting of Shareholders
12:30pm, Tuesday, 26'th May 2020
LONDON and NEW YORK, May 26, 2020 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (MGTX), a vertically integrated, clinical stage gene therapy company, today announced that its 2020 Annual General Meet
MeiraGTx Reports First Quarter 2020 Financial Results
08:30pm, Thursday, 07'th May 2020
LONDON and NEW YORK, May 07, 2020 -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial.
MeiraGTx to Present at the Virtual Bank of America Securities 2020 Health Care Conference
08:30pm, Wednesday, 06'th May 2020
LONDON and NEW YORK, May 06, 2020 -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced.
